In anticipation of next week's BEYOND OPTIMIZE virtual event, the author chats with WRE, Inc.'s Harvey Welker about his session on ACCE.

Advances in the application of artificial intelligence (AI) are starting to have a significant impact on automation technologies used across industry—most notably with machine vision and analytics. And some of the more impactful applications of AI are happening in the pharmaceutical industries. Learn more in this article from Automation World.

As digitalization initiatives sweep through engineering departments at both EPC and Owner companies, executives are striving to better connect their design, engineering and estimating workflows. With improved design outcomes and more accurate and timely estimating on the line, the clock is ticking to deliver results from these initiatives.

Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laboratory assays were too time consuming to provide meaningful feedback for real-time control, and 100% product quality inspection was not possible.

Pharmaceutical companies, CDMOs and CMOs face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these challenges by increasing saleable product through more consistent quality, higher yields and greater throughput. In addition, digitalization advances such as extensive connectivity, increased and elastic computing power, and advanced analytics have all continued to strengthen the accessibility and power of PAT to accelerate market growth.

Braskem's Digital Transformation Manager shares some highlights of his upcoming Beyond OPTIMIZE presentation and the sessions that interest him to share best practices with other users.

Today’s asset intensive organizations face multiple competitive, market and economic related challenges, not the least of them relates to managing the business during a pandemic. This drives the need for new and expanded asset performance capabilities that go beyond traditional maintenance management approaches to include improved access to process data.

This presentation by ExxonMobil from OPTIMIZE 2021™ reviews their progress on the quest to enable “integrative design” where the elements of engineering, execution and cost are considered in a holistic environment by the project concept team.

In this article from European Pharmaceutical Review, David Leitham, Senior Vice President and General Manager at AspenTech®, explains how implementing PAT pushes the industry towards Pharma 4.0. Download this article to learn more.

In this blog, our author answers the question: “Why is digital transformation so critical to your paper mill achieving its overall goals?”